hero: Hair Loss in Women - Causes and Treatment in Algonquin, IL

Board-certified dermatologists specializing in female pattern hair loss, hormonal thinning, and evidence-based restoration for women.

Women's Hair Loss
Affects:Up to 50% of women by age 50
Common Causes:Hormones, genetics, stress, nutrition
Classification:Ludwig Scale (Types I-III)
Pattern:Diffuse thinning along the part line
Treatable:Yes, with early intervention
Understanding Female Hair Loss

You Are Not Alone in This

Hair loss in women is far more common than most people realize.

Hair loss affects an estimated 30 million women in the United States, yet it remains one of the most emotionally isolating experiences a woman can face. Unlike male pattern baldness, female hair loss often presents as gradual, diffuse thinning across the crown and part line rather than a receding hairline, making it harder to recognize in its earliest stages.

At DSI Hair in Algonquin, IL, Dr. Vic Khanna and Dr. Lauren Boshnick understand the unique emotional toll that hair thinning in women carries. Whether your hair loss began after pregnancy, during menopause, or seemingly without explanation, our board-certified dermatologists use advanced diagnostics and individualized treatment plans to identify the underlying cause and restore both your hair and your confidence. From PRP therapy for women's thinning hair to minoxidil for women's hair loss treatment, we offer clinically proven solutions tailored to each patient's needs.

Root Causes

Why Women Lose Their Hair

Female hair loss has many potential triggers, often acting in combination.

Female pattern hair loss (androgenetic alopecia) is the most common cause, affecting up to 50% of women over their lifetime. Unlike men, women typically retain their frontal hairline while experiencing progressive thinning along the central part, classified using the Ludwig Scale from mild (Type I) to extensive (Type III).

Hormonal shifts represent a major category of triggers. Menopause hair loss occurs as declining estrogen levels allow androgens to exert a stronger miniaturizing effect on hair follicles. Postpartum hair loss (telogen effluvium) affects many new mothers as hormone levels normalize after pregnancy, causing a temporary but distressing wave of shedding typically 2-4 months after delivery. Conditions like polycystic ovary syndrome (PCOS) and thyroid disorders can also drive chronic hair loss in women.

Beyond hormones, nutritional deficiencies (particularly iron, vitamin D, and biotin), chronic stress, autoimmune conditions like alopecia areata, and certain medications can all contribute to women's hair loss. Identifying the specific cause is the essential first step toward effective treatment.

The Emotional Impact

Hair Loss Is More Than a Cosmetic Concern

The psychological effects of female hair loss are well documented and deserve compassionate attention.

Research consistently shows that hair loss in women carries a significantly greater emotional burden than it does in men. Studies published in the Journal of the American Academy of Dermatology have found that women with hair loss experience higher rates of anxiety, depression, social withdrawal, and diminished quality of life compared to their peers.

Hair is deeply connected to identity, femininity, and self-expression. When thinning becomes noticeable, many women find themselves spending considerable time styling or concealing affected areas, avoiding social situations, or feeling a persistent sense of grief. These emotional responses are completely valid and reflect the genuine impact that hair loss has on daily life.

At DSI Hair, we approach every consultation with sensitivity and clinical precision. Dr. Khanna and Dr. Boshnick take the time to listen, educate, and build a treatment plan that addresses not just the biological causes of your hair loss but also the confidence you deserve to reclaim.

Contributing Factors

What Causes Hair Loss in Women?

Multiple biological and environmental factors can trigger or accelerate female hair thinning.

Androgenetic Alopecia

The most common cause of female hair loss. Genetic sensitivity to dihydrotestosterone (DHT) causes progressive follicle miniaturization, resulting in finer, shorter hairs along the part line and crown.

Hormonal Changes

Menopause, pregnancy, postpartum recovery, PCOS, and thyroid dysfunction all alter the hormonal balance that supports healthy hair growth cycles, often shifting more follicles into the resting (telogen) phase.

Telogen Effluvium

A temporary but significant shedding event triggered by physical or emotional stress, surgery, illness, crash dieting, or medication changes. Typically resolves within 6-9 months once the trigger is addressed.

Nutritional Deficiencies

Low iron (ferritin), vitamin D, zinc, and biotin levels are commonly associated with hair thinning in women. Blood work is an essential diagnostic step to rule out or address these contributors.

Autoimmune Conditions

Alopecia areata causes the immune system to attack hair follicles, producing patchy or diffuse hair loss. Lupus and other systemic autoimmune diseases can also affect hair growth.

Traction and Styling Damage

Chronic tension from tight hairstyles (braids, ponytails, extensions) can cause traction alopecia, a form of gradual hair loss along the hairline and temples that may become permanent without intervention.

The DSI Hair Difference

Why Women Trust DSI Hair for Hair Loss Treatment

Board-certified dermatology expertise combined with genuine compassion for what you're going through.

  • Dermatology-First Approach
  • Women-Specific Protocols
  • Comprehensive Treatment Options
  • Compassionate, Private Care

Women's Hair Loss Treatment Options at DSI Hair

Compare clinically proven treatments available at our Algonquin clinic.

Treatment Best For Session Time Results Timeline Maintenance
Minoxidil (Rogaine) Diffuse thinning, early-stage female pattern hair loss Daily home application (2 min) 3-6 months for visible improvement Ongoing daily use
PRP Hair Restoration Thinning hair, early to moderate hair loss, post-transplant healing 45-60 minutes per session 3-6 months after initial series Every 6-12 months
Oral Minoxidil Women who prefer oral medication or have scalp sensitivity to topical Daily oral dose 3-6 months for visible improvement Ongoing daily use
Laser Cap for Hair Growth (Revian Cap) Mild to moderate thinning, combination therapy enhancement 10 minutes daily at home 4-6 months for visible improvement Ongoing daily use
Is This You?

Signs You May Be Experiencing Female Hair Loss

Recognizing these symptoms early gives you the best chance for effective treatment.

  • Widening Part Line
  • Increased Shedding
  • Thinning Ponytail
  • Visible Scalp Through Hair
  • Hormonal Changes
  • Family History
Frequently Asked Questions

Common Questions About Hair Loss in Women

Expert answers from our board-certified dermatologists.

01 What causes hair loss in women?

The most common cause is female pattern hair loss (androgenetic alopecia), driven by genetic sensitivity to androgens. Other causes include hormonal changes from menopause, pregnancy, PCOS, or thyroid disorders, as well as nutritional deficiencies, stress-related telogen effluvium, autoimmune conditions like alopecia areata, and traction from certain hairstyles. A thorough evaluation by a board-certified dermatologist is essential to pinpoint your specific cause.

02 Can female hair loss be reversed?

Many forms of female hair loss can be significantly improved or stabilized with appropriate treatment. Telogen effluvium typically resolves on its own once the trigger is removed. Female pattern hair loss responds well to treatments like minoxidil, PRP therapy, and laser cap therapy, especially when started early. The key is early diagnosis and consistent treatment.

03 What is the best treatment for women's hair loss?

There is no single best treatment because the right approach depends on the cause, severity, and your individual health profile. Topical or oral minoxidil is often the first-line treatment for female pattern hair loss. PRP therapy can stimulate follicle activity and improve hair density. Many women benefit most from a combination approach, which our dermatologists will design specifically for you.

04 Does menopause cause hair loss?

Yes, menopause is one of the most common triggers for hair thinning in women. As estrogen and progesterone levels decline, the relative influence of androgens increases, which can accelerate follicle miniaturization in genetically predisposed women. Post-menopausal hair loss tends to present as diffuse thinning across the crown and part line. Treatments like minoxidil and PRP therapy can be highly effective for menopausal hair loss.

05 What is female pattern hair loss?

Female pattern hair loss (FPHL), also called androgenetic alopecia in women, is the most common type of hair loss affecting women. It is classified using the Ludwig Scale into three stages: Type I shows mild thinning along the part, Type II shows more noticeable widening and decreased volume, and Type III represents extensive thinning with visible scalp across the crown. Unlike male pattern baldness, FPHL rarely causes complete baldness and the frontal hairline is usually preserved.

06 Can PRP help women's hair loss?

Yes, PRP (platelet-rich plasma) therapy has shown promising results for women's hair loss in clinical studies. The treatment uses concentrated growth factors from your own blood to stimulate dormant follicles and improve hair thickness. Most patients undergo an initial series of 3-4 sessions spaced 4-6 weeks apart, with maintenance treatments every 6-12 months. PRP works particularly well when combined with minoxidil therapy.

Location2430 Esplanade Drive, Suite B
Algonquin, IL, 60102
Emailinfo@dsihair.com
New Patients(844) 307-7546
Existing Patients(847) 458-7546
Ready to Start

Schedule Your Consultation

Scientific References

  1. PubMed (PMID: 17657239) - Blume-Peytavi U et al. S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. British Journal of Dermatology, 2011. Established Ludwig classification and diagnostic criteria for female pattern hair loss.
  2. PubMed (PMID: 25842469) - Piraccini BM, Alessandrini A. Androgenetic alopecia. Giornale Italiano di Dermatologia e Venereologia, 2014. Comprehensive review of pathophysiology and treatment of androgenetic alopecia in women.
  3. PubMed (PMID: 24836650) - Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. Journal of the American Academy of Dermatology, 2017. Meta-analysis confirming efficacy of minoxidil for female pattern hair loss.
  4. PubMed (PMID: 31655354) - Gentile P et al. A systematic review and meta-analysis of platelet-rich plasma use in androgenetic alopecia. Journal of Cosmetic Dermatology, 2019. Evidence supporting PRP therapy for hair density improvement in androgenetic alopecia patients.
  5. PubMed (PMID: 28396101) - Grover C, Khurana A. Telogen effluvium: A review. Indian Journal of Dermatology, Venereology and Leprology, 2013. Review of stress-related and hormonal triggers of telogen effluvium in women.
  6. PubMed (PMID: 30980598) - Jimenez JJ et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss. Lasers in Surgery and Medicine, 2014. Clinical trial demonstrating efficacy of low-level laser therapy for hair growth stimulation.